Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding. - Suppr | 超能文献

Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.

作者信息

Seiler M P, Markstein R

出版信息

Mol Pharmacol. 1982 Sep;22(2):281-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.

Mol Pharmacol. 1982 Sep;22(2):281-9.

2

Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.纹状体多巴胺D2受体激动剂结构要求的进一步表征及其与纹状体多巴胺D1受体激动剂结构要求的比较。用一系列单羟基氨基四氢萘对大鼠纹状体乙酰胆碱释放的研究。

Mol Pharmacol. 1984 Nov;26(3):452-7.

3

Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.

Synapse. 1990;5(4):336-7. doi: 10.1002/syn.890050411.

4

A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.

J Pharmacol Exp Ther. 1982 Nov;223(2):298-304.

5

Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.一些2-羟基苄基哌啶与多巴胺受体的相互作用。

Farmaco Sci. 1987 Apr;42(4):307-17.

6

Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.通过给予左旋多巴逆转多巴胺受体超敏反应的两种表现。

Res Commun Chem Pathol Pharmacol. 1977 Mar;16(3):411-23.

7

Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.慢性舒必利治疗会使性未成熟或成年去势大鼠的纹状体腺苷酸环化酶对多巴胺产生超敏反应。

J Pharmacol Exp Ther. 1983 Mar;224(3):627-33.

8

Detection of multiple receptors for dopamine.多巴胺多种受体的检测

Adv Biochem Psychopharmacol. 1980;21:243-51.

9

Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.

Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):487-93. doi: 10.1007/BF00169304.

10

Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.

Pol J Pharmacol Pharm. 1985 May-Jun;37(3):253-61.

引用本文的文献

1

Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.使用光致变色 tethered 反向激动剂对多巴胺受体进行光学控制。

J Am Chem Soc. 2017 Dec 27;139(51):18522-18535. doi: 10.1021/jacs.7b07659. Epub 2017 Dec 13.

2

A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(2):108-15. doi: 10.1007/BF00497015.

3

[3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.[3H]205 - 501，一种非儿茶酚胺多巴胺能激动剂，能选择性且高亲和力地标记多巴胺D2受体。

J Neural Transm. 1985;62(3-4):231-48. doi: 10.1007/BF01252239.

4

Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergolene.新型8β-麦角灵CK 204-933的生化、行为及内分泌效应

J Neural Transm. 1987;69(3-4):179-99. doi: 10.1007/BF01244340.